|
Name |
6,10-Dimethylundecan-2-one
|
| Molecular Formula | C13H26O | |
| IUPAC Name* |
6,10-dimethylundecan-2-one
|
|
| SMILES |
CC(C)CCCC(C)CCCC(=O)C
|
|
| InChI |
InChI=1S/C13H26O/c1-11(2)7-5-8-12(3)9-6-10-13(4)14/h11-12H,5-10H2,1-4H3
|
|
| InChIKey |
RBGLEUBCAJNCTR-UHFFFAOYSA-N
|
|
| Synonyms |
6,10-Dimethylundecan-2-one; Hexahydropseudoionone; 2-Undecanone, 6,10-dimethyl-; 6,10-Dimethyl-2-undecanone; 1604-34-8; Tetrahydrogeranylacetone; Pseudoionone, hexahydro-; NSC-15338; 91TGG00357; UNII-91TGG00357; NSC15338; EINECS 216-509-8; EINECS 262-082-6; NSC 15338; AI3-15989; 2-Undecanone,10-dimethyl-; 60148-93-8; SCHEMBL117939; 6,10-dimethylundecane-2-one; DTXSID80862709; (1)-6,10-Dimethylundecan-2-one; STL562193; 2,6-DIMETHYLUNDECANE-10-ONE; AKOS006281602; CS-0263271; E85200; EN300-8588865; Q27271425
|
|
| CAS | 1604-34-8 | |
| PubChem CID | 95495 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 198.34 | ALogp: | 4.5 |
| HBD: | 0 | HBA: | 1 |
| Rotatable Bonds: | 8 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 17.1 | Aromatic Rings: | 0 |
| Heavy Atoms: | 14 | QED Weighted: | 0.548 |
| Caco-2 Permeability: | -4.38 | MDCK Permeability: | 0.00001560 |
| Pgp-inhibitor: | 0.032 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.958 |
| 30% Bioavailability (F30%): | 0.954 |
| Blood-Brain-Barrier Penetration (BBB): | 0.903 | Plasma Protein Binding (PPB): | 96.04% |
| Volume Distribution (VD): | 1.21 | Fu: | 2.98% |
| CYP1A2-inhibitor: | 0.716 | CYP1A2-substrate: | 0.563 |
| CYP2C19-inhibitor: | 0.464 | CYP2C19-substrate: | 0.82 |
| CYP2C9-inhibitor: | 0.606 | CYP2C9-substrate: | 0.954 |
| CYP2D6-inhibitor: | 0.023 | CYP2D6-substrate: | 0.155 |
| CYP3A4-inhibitor: | 0.053 | CYP3A4-substrate: | 0.169 |
| Clearance (CL): | 7.597 | Half-life (T1/2): | 0.413 |
| hERG Blockers: | 0.025 | Human Hepatotoxicity (H-HT): | 0.048 |
| Drug-inuced Liver Injury (DILI): | 0.15 | AMES Toxicity: | 0.004 |
| Rat Oral Acute Toxicity: | 0.017 | Maximum Recommended Daily Dose: | 0.021 |
| Skin Sensitization: | 0.69 | Carcinogencity: | 0.056 |
| Eye Corrosion: | 0.985 | Eye Irritation: | 0.97 |
| Respiratory Toxicity: | 0.094 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001798 | ![]() |
0.667 | D00FSV | ![]() |
0.333 | ||
| ENC001286 | ![]() |
0.571 | D03LGY | ![]() |
0.250 | ||
| ENC000622 | ![]() |
0.571 | D00WUF | ![]() |
0.250 | ||
| ENC000536 | ![]() |
0.571 | D0UU9Y | ![]() |
0.244 | ||
| ENC000902 | ![]() |
0.538 | D0Y3KG | ![]() |
0.235 | ||
| ENC000537 | ![]() |
0.538 | D09QEI | ![]() |
0.230 | ||
| ENC000503 | ![]() |
0.537 | D0ZI4H | ![]() |
0.221 | ||
| ENC000581 | ![]() |
0.535 | D0FD0H | ![]() |
0.220 | ||
| ENC000354 | ![]() |
0.517 | D0D9NY | ![]() |
0.220 | ||
| ENC001722 | ![]() |
0.516 | D0ZK8H | ![]() |
0.213 | ||